These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12618906)

  • 41. Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B.
    Wiszniewski W; Fondaneche MC; Lambert N; Masternak K; Picard C; Notarangelo L; Schwartz K; Bal J; Reith W; Alcaide C; de Saint Basile G; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2000 Apr; 51(4-5):261-7. PubMed ID: 10803838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MHC class II regulatory factor RFX has a novel DNA-binding domain and a functionally independent dimerization domain.
    Reith W; Herrero-Sanchez C; Kobr M; Silacci P; Berte C; Barras E; Fey S; Mach B
    Genes Dev; 1990 Sep; 4(9):1528-40. PubMed ID: 2253877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutation in the class II trans-activator leading to a mild immunodeficiency.
    Wiszniewski W; Fondaneche MC; Le Deist F; Kanariou M; Selz F; Brousse N; Steimle V; Barbieri G; Alcaide-Loridan C; Charron D; Fischer A; Lisowska-Grospierre B
    J Immunol; 2001 Aug; 167(3):1787-94. PubMed ID: 11466404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antisense oligonucleotides specific for regulatory factor RFX-1 inhibit inducible but not constitutive expression of all major histocompatibility complex class II genes.
    Siegrist CA; Mach B
    Eur J Immunol; 1993 Nov; 23(11):2903-8. PubMed ID: 8223867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.
    Scholl T; Mahanta SK; Strominger JL
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6330-4. PubMed ID: 9177217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.
    Hake SB; Masternak K; Kammerbauer C; Janzen C; Reith W; Steimle V
    Mol Cell Biol; 2000 Oct; 20(20):7716-25. PubMed ID: 11003667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solution structure of the heterotrimeric complex between the interaction domains of RFX5 and RFXAP from the RFX gene regulatory complex.
    Laird KM; Briggs LL; Boss JM; Summers MF; Garvie CW
    J Mol Biol; 2010 Oct; 403(1):40-51. PubMed ID: 20732328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.
    Durand B; Kobr M; Reith W; Mach B
    Mol Cell Biol; 1994 Oct; 14(10):6839-47. PubMed ID: 7935401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency.
    Matheux F; Ikinciogullari A; Zapata DA; Barras E; Zufferey M; Dogu F; Regueiro JR; Reith W; Villard J
    Mol Ther; 2002 Dec; 6(6):824-9. PubMed ID: 12498778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.
    Naamane H; El Maataoui O; Ailal F; Barakat A; Bennani S; Najib J; Hassar M; Saile R; Bousfiha AA
    Eur J Pediatr; 2010 Sep; 169(9):1069-74. PubMed ID: 20414676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.
    Krawczyk M; Peyraud N; Rybtsova N; Masternak K; Bucher P; Barras E; Reith W
    J Immunol; 2004 Nov; 173(10):6200-10. PubMed ID: 15528357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5.
    Peijnenburg A; Van Eggermond MJ; Gobin SJ; Van den Berg R; Godthelp BC; Vossen JM; Van den Elsen PJ
    J Immunol; 1999 Jul; 163(2):794-801. PubMed ID: 10395672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y.
    Reith W; Siegrist CA; Durand B; Barras E; Mach B
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):554-8. PubMed ID: 8290561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.
    Seguín-Estévez Q; De Palma R; Krawczyk M; Leimgruber E; Villard J; Picard C; Tagliamacco A; Abbate G; Gorski J; Nocera A; Reith W
    J Immunol; 2009 Aug; 183(4):2545-53. PubMed ID: 19620312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MHC-II Deficiency Among Egyptians: Novel Mutations and Unique Phenotypes.
    El Hawary RE; Mauracher AA; Meshaal SS; Eldash A; Abd Elaziz DS; Alkady R; Lotfy S; Opitz L; Galal NM; Boutros JA; Pachlopnik Schmid J; Elmarsafy AM
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):856-863. PubMed ID: 30170160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters.
    Reith W; Kobr M; Emery P; Durand B; Siegrist CA; Mach B
    J Biol Chem; 1994 Aug; 269(31):20020-5. PubMed ID: 8051086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
    Masternak K; Reith W
    EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population.
    Mousavi Khorshidi MS; Seeleuthner Y; Chavoshzadeh Z; Behfar M; Hamidieh AA; Alimadadi H; Sherkat R; Momen T; Behniafard N; Eskandarzadeh S; Mansouri M; Behnam M; Mahdavi M; Heydarazad Zadeh M; Shokri M; Alizadeh F; Movahedi M; Momenilandi M; Keramatipour M; Casanova JL; Cobat A; Abel L; Shahrooei M; Parvaneh N
    J Clin Immunol; 2023 Nov; 43(8):1941-1952. PubMed ID: 37584719
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module.
    Ludigs K; Seguín-Estévez Q; Lemeille S; Ferrero I; Rota G; Chelbi S; Mattmann C; MacDonald HR; Reith W; Guarda G
    PLoS Genet; 2015 Mar; 11(3):e1005088. PubMed ID: 25811463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome.
    Moreno CS; Emery P; West JE; Durand B; Reith W; Mach B; Boss JM
    J Immunol; 1995 Nov; 155(9):4313-21. PubMed ID: 7594590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.